StockNews.com upgraded shares of Cadiz (NASDAQ:CDZI – Free Report) to a sell rating in a research report sent to investors on Friday morning.
Cadiz Stock Up 2.5 %
CDZI stock opened at $3.32 on Friday. The firm has a market cap of $226.36 million, a PE ratio of -6.51 and a beta of 0.85. Cadiz has a 1 year low of $2.12 and a 1 year high of $3.85. The company has a fifty day simple moving average of $3.15 and a 200 day simple moving average of $3.14. The company has a current ratio of 1.36, a quick ratio of 1.40 and a debt-to-equity ratio of 3.88.
Insider Activity
In other news, major shareholder International Group Se Heerema acquired 2,070,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was acquired at an average cost of $3.34 per share, with a total value of $6,913,800.00. Following the acquisition, the insider now owns 22,783,965 shares in the company, valued at approximately $76,098,443.10. This represents a 9.99 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.70% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Cadiz Company Profile
Cadiz Inc, together with its subsidiaries, provides water solutions in the United States. The company operates through Land and Water Resources; and Water Filtration Technology segments. It offers water supply, water storage, water conveyance, and water filtration services. In addition, the company is involved in the cultivation of grain crops and alfalfa, as well as provides water filtration solutions for impaired or contaminated groundwater sources.
See Also
- Five stocks we like better than Cadiz
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Investing in Travel Stocks Benefits
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Cadiz Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadiz and related companies with MarketBeat.com's FREE daily email newsletter.